Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00529113
Status:
TERMINATED
Last Update Posted:
2024-02-02
First Post:
2007-09-12
Brief Title:
Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer
Sponsor:
Reata a wholly owned subsidiary of Biogen
Organization:
Biogen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2009-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-09-12
First Submit QC Date:
September 12 2007
Study First Post Date:
2007-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-01
Last Update Post Date:
2024-02-02
Last Update Post Date Type:
ACTUAL